Fifth Third Bancorp Takes $1.53 Million Position in National Research Corporation $NRC

Fifth Third Bancorp purchased a new position in shares of National Research Corporation (NASDAQ:NRC) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 90,182 shares of the company’s stock, valued at approximately $1,531,000.

Other large investors also recently modified their holdings of the company. Cubist Systematic Strategies LLC purchased a new position in shares of National Research during the first quarter worth about $118,000. AQR Capital Management LLC lifted its holdings in shares of National Research by 168.6% in the 1st quarter. AQR Capital Management LLC now owns 108,134 shares of the company’s stock valued at $1,384,000 after purchasing an additional 67,882 shares during the last quarter. Jane Street Group LLC lifted its holdings in shares of National Research by 394.2% in the 1st quarter. Jane Street Group LLC now owns 52,411 shares of the company’s stock valued at $671,000 after purchasing an additional 41,806 shares during the last quarter. Strs Ohio acquired a new stake in shares of National Research in the 1st quarter valued at about $33,000. Finally, M&T Bank Corp boosted its position in shares of National Research by 6.4% in the 2nd quarter. M&T Bank Corp now owns 13,608 shares of the company’s stock valued at $229,000 after purchasing an additional 823 shares during the period. 47.26% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research firms have commented on NRC. Citizens Jmp initiated coverage on National Research in a research report on Monday, June 22nd. They set a “market outperform” rating and a $23.00 price target on the stock. Weiss Ratings raised National Research from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, May 29th. One investment analyst has rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $23.00.

National Research Trading Down 3.5%

Shares of NRC stock opened at $20.83 on Friday. The company has a market capitalization of $473.88 million, a P/E ratio of 53.41 and a beta of 0.35. The company has a current ratio of 0.52, a quick ratio of 0.52 and a debt-to-equity ratio of 5.48. The business’s 50 day moving average is $20.28 and its two-hundred day moving average is $18.28. National Research Corporation has a twelve month low of $11.01 and a twelve month high of $23.00.

National Research (NASDAQ:NRC) last released its quarterly earnings results on Tuesday, April 28th. The company reported $0.21 EPS for the quarter. National Research had a return on equity of 122.73% and a net margin of 6.52%.The business had revenue of $34.80 million during the quarter.

National Research Profile

National Research Corp (NASDAQ: NRC), also known as NRC Health, is a healthcare analytics and performance improvement company specializing in patient and employee experience measurement. The company’s cloud-based platform enables healthcare providers to collect real-time feedback through patient satisfaction surveys, post-discharge outreach, and employee engagement tools. NRC Health integrates clinical, operational and financial data to deliver actionable insights that support quality improvement initiatives and value-based care programs.

Since its founding in the early 1990s and headquartered in Lincoln, Nebraska, National Research has expanded beyond its regional roots to serve more than 1,600 hospitals and 12,000 care sites across the United States and Canada.